Status:
WITHDRAWN
Evaluation of Six-month HIV Treatment Dispensing in South Africa
Lead Sponsor:
Boston University
Collaborating Sponsors:
Bill and Melinda Gates Foundation
University of Witwatersrand, South Africa
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
Many countries in sub-Saharan Africa are implementing a policy of six-month dispensing of antiretroviral (ARV) medications for HIV. Under the new guidelines, stable patients can receive a six-month su...
Detailed Description
The overall aims of this study are to assess the uptake and impact of six-month medication dispensing (6MMD) on HIV patients' treatment outcomes at public-sector clinics; estimate the costs of the int...
Eligibility Criteria
Inclusion
- Objectives 1 and 2: On same ART treatment regimen for at least 6 months; most recent viral load taken in the past 6 months; and last viral load undetectable (\<50 copies/ml3)
- Objective 3: Patient at an intervention site who meets the eligibility criteria for 6MMD; or provider at an intervention site
Exclusion
- Objectives 1 and 2: Not resident in the facility's catchment area; recorded intention to transfer care to a different facility within 12 months; or pregnant and eligible for PMTCT
- Objective 3: Not resident in the facility's catchment area; recorded intention to transfer care to a different facility within 12 months; pregnant and eligible for PMTCT; unable to communicate in one of the language into which the consent documents and questionnaire have been translated
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04468789
Start Date
November 1 2020
End Date
December 1 2022
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Economics and Epidemiology Research Office
Johannesburg, Gauteng, South Africa, 2193